DVDavis P. Viprakasit

Davis P. Viprakasit

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Davis P. Viprakasit has a total of 51 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prevention of Recurrent Nephrolithiasis in Adults and Children

    by Gary N. Asher, Davis P. Viprakasit, Shannon E. Aymes, Jay B. Lusk, Sherry Ross, Claire Baker, Caroline Rains, Sarah T. Wright, Leila C. Kahwati

    Nephrolithiasis (kidney stones) commonly affects children and adults. Recurrent kidney stones may lead to kidney damage, sepsis, or invasive procedures. This systematic review aimed to synthesize e... Background: Recurrent kidney stones are unpleasant and may lead to kidney damage, sepsis, or invasive procedures. Purpose: To assess benefits and harms of diet, pharmacologic therapy, and surveilla...


  • The Impact of Bilateral Stone Disease on Patients' Disease Progression and Health-Related Quality of Life

    by Brendan L. Raizenne, Claudia Deyirmendjian, Marie-Lyssa Lafontaine, Maimouna Balde, Seth K. Bechis, Roger L. Sur, Stephen Y. Nakada, Jodi A. Antonelli, Necole M. Streeper, Sri Sivalingam, et al.

    Purpose Patients with recurring kidney stone events can expect significant morbidity and functional impairment. Few studies have evaluated the effect of bilateral kidney stones on disease progression and quality of life. We wanted to determine the association of bilateral stone disease on age of onset, and the impact on number of stone events and individual kidney stone disease specific Health Related Quality of Life (HRQOL) by analysing the validated and prospectively collected Wisconsin Stone Quality of Life (WISQOL) database. Material and Methods We studied 2,906 stone patients from 16 centers in North America after having completed the WISQOL questionnaire from 2014 to 2019. Kidney stone formers were assessed if kidney stones were bilateral or unilateral on imaging. Analysis with a Chi-square test compared categorical variables. Bilateral kidney stone disease and its impact on HRQOL was evaluated through a multivariable linear regression model. Results Of 2,906 kidney stone formers, 1,340 had unilateral kidney stones and 1,566 had bilateral kidney stones. We observed more frequently that patients with bilateral stones had an increased number of depression/anxiety symptoms, renal tubular acidosis, and rheumatoid arthritis (all p<0.05). Patients with bilateral stones had a younger mean (SD) age of kidney stone disease onset (37.2±15.8 vs 46.4±15.9 years of age, p<0.001). Bilateral kidney stone formers had a higher mean (SD) number of stone events (11.3±21.8) than unilateral kidney stone formers (3.0±5.1) (p<0.001). Within our multivariable analysis, we found that HRQOL was negatively affected by the presence of bilateral stones for kidney stone patients (β=-11.2 (CI:-19.5 - -3.0) points, p<0.05). Conclusion Bilateral kidney stone formers had a younger age of kidney stone disease onset and a higher number of stone events compared to unilateral kidney stone disease formers. Presence of bilateral kidney stone disease negatively impacted HRQOL.


  • Predictors and Cost Comparison of Subsequent Urinary Stone Care at Index Versus Non-Index Hospitals

    by William W. French, Charles D. Scales, Davis P. Viprakasit, Roger L. Sur, David F. Friedlander


  • Open Access

    The effect of travel distance on health-related quality of life for patients with nephrolithiasis

    by Gopal L. Narang, Laura E. Wiener, Kristina L. Penniston, Jodi A. Antonelli, Timothy D. Averch, Sri Sivalingam, Ben H. Chew, Vincent G. Bird, Vernon M. Pais Jr., Roger L. Sur, et al.

    Introduction: Urolithiasis causes a significant impact on health-related quality of life (HRQOL). Patients with kidney stones have high levels of stress and anxiety. Symptom resolution often requires treatment. Travel distance is a barrier to care but little is known about its effects on HRQOL. We hypothesize that increased distance to treatment site is associated with decreased HRQOL. Methods: Patients with a history of stones were enrolled at 11 tertiary centers as part of the QOL Stone Consortium of North America. HRQOL data were obtained using the Wisconsin Stone Quality of Life questionnaire (WISQOL). We calculated distance between patient and treatment site using national ZIP codes. We used linear models to evaluate the effect of distance on HRQOL, while also considering demographics data, stones/symptom status, and distance. Results: Of the 1676 enrolled patients, 52% were male, 86% non-Latino White, and the mean age was 53 years. Mean distance to treatment site was 63.3 km (range: 0–3774), with 74% reporting current stones and 45% current symptoms. WISQOL score and distance were negatively correlated for patients reporting current stones and symptoms (p=0.0010). Linear modelling revealed decreased WISQOL scores for patients with symptoms as distance increased from treatment site (p=0.0001), with a 4.7-point decrease for every 100 km traveled. Conclusions: Stone disease imposes significant burden on patients’ HRQOL due to a variety of factors. Patients with active stone symptoms report worse HRQOL with increased distance to their treatment site. Possible etiologies include travel burden, increased disease burden, decreased healthcare use, and delays in care.


  • 471: PSA Velocity Threshold for Predicting Prostate Cancer in Young Men with PSA < 4 ng/ml

    by Stacy Loeb, Kimberly A. Roehl, Theresa Graif, Davis Viprakasit, William J. Catalona, Robert B. Nadler